TOKYO, Oct 6 (Reuters) - The Japanese government said on Tuesday it would buy enough H1N1 flu vaccine from British drug maker GlaxoSmithKline (GSK.L) and Switzerland's Novartis (NOVN.VX) to treat nearly 50 million people.
The government said last week it would secure enough to treat a total of 77 million people by the end of March next year, with Japanese makers producing enough vaccine to treat 27 million people. It added that it would start importing vaccine from around the end of December or January.
Experts predict that a third of the global population - 2 billion people - will eventually be infected with H1N1, which was first seen in March in California and Mexico.
The World Health Organization said in late August that the new H1N1 swine flu had reached epidemic levels in Japan, signaling the early start to what may be a long influenza season this year.
...
reuters.com
Last August swine flu reached "epidemic levels"? I remember the government closing the schools for a week and quarantining a plane full of people for a while, but it turned out only a few people had it. But I guess if a third of the world's population will get it eventually now would be a good time.